These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 7474132)

  • 21. Deletion of a single N-linked glycosylation site from the transmembrane envelope protein of human immunodeficiency virus type 1 stops cleavage and transport of gp160 preventing env-mediated fusion.
    Dash B; McIntosh A; Barrett W; Daniels R
    J Gen Virol; 1994 Jun; 75 ( Pt 6)():1389-97. PubMed ID: 8207403
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sulfation of the human immunodeficiency virus envelope glycoprotein.
    Bernstein HB; Compans RW
    J Virol; 1992 Dec; 66(12):6953-9. PubMed ID: 1433500
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mapping of the human immunodeficiency virus type 2 envelope glycoprotein CD4 binding region and fusion domain with truncated proteins expressed by recombinant vaccinia viruses.
    Otteken A; Voss G; Hunsmann G
    Virology; 1993 May; 194(1):37-43. PubMed ID: 8480426
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A furin-defective cell line is able to process correctly the gp160 of human immunodeficiency virus type 1.
    Ohnishi Y; Shioda T; Nakayama K; Iwata S; Gotoh B; Hamaguchi M; Nagai Y
    J Virol; 1994 Jun; 68(6):4075-9. PubMed ID: 8189547
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Normal T cell receptor-mediated signaling in T cell lines stably expressing HIV-1 envelope glycoproteins.
    Tani Y; Tian H; Lane HC; Cohen DI
    J Immunol; 1993 Dec; 151(12):7337-48. PubMed ID: 7903106
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of endoproteolytic cleavage and intracellular transport of human immunodeficiency virus type 1 envelope glycoproteins using mutant CD4 molecules bearing the transmembrane endoplasmic reticulum retention signal.
    Raja NU; Vincent MJ; Jabbar MA
    J Gen Virol; 1993 Oct; 74 ( Pt 10)():2085-97. PubMed ID: 8409933
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation between high level gp160 expression and reduced CD4 biosynthesis in clonal derivatives of human immunodeficiency virus type 1-infected U-937 cells.
    Geleziunas R; Bour S; Wainberg MA
    J Gen Virol; 1994 Apr; 75 ( Pt 4)():857-65. PubMed ID: 8151301
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduced cell surface expression of processed human immunodeficiency virus type 1 envelope glycoprotein in the presence of Nef.
    Schwartz O; Rivière Y; Heard JM; Danos O
    J Virol; 1993 Jun; 67(6):3274-80. PubMed ID: 8497051
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biological properties of recombinant HIV envelope synthesized in CHO glycosylation-mutant cell lines.
    Fenouillet E; Miquelis R; Drillien R
    Virology; 1996 Apr; 218(1):224-31. PubMed ID: 8615025
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased envelope spike density and stability are not required for the neutralization resistance of primary human immunodeficiency viruses.
    Karlsson GB; Gao F; Robinson J; Hahn B; Sodroski J
    J Virol; 1996 Sep; 70(9):6136-42. PubMed ID: 8709238
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biochemical and genetic definition of the cellular protease required for HIV-1 gp160 processing.
    Franzusoff A; Volpe AM; Josse D; Pichuantes S; Wolf JR
    J Biol Chem; 1995 Feb; 270(7):3154-9. PubMed ID: 7852398
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression and processing of the human immunodeficiency virus type 1 envelope glycoprotein.
    Chen SS
    Intervirology; 1996; 39(4):242-8. PubMed ID: 9078465
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Restoration of cell surface CD4 expression in human immunodeficiency virus type 1-infected cells by treatment with a Tat antagonist.
    Shahabuddin M; Volsky B; Hsu MC; Volsky DJ
    J Virol; 1992 Nov; 66(11):6802-5. PubMed ID: 1404619
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intracellular membrane traffic of human immunodeficiency virus type 1 envelope glycoproteins: vpu liberates Golgi-targeted gp160 from CD4-dependent retention in the endoplasmic reticulum.
    Kimura T; Nishikawa M; Ohyama A
    J Biochem; 1994 May; 115(5):1010-20. PubMed ID: 7961587
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional role of the glycan cluster of the human immunodeficiency virus type 1 transmembrane glycoprotein (gp41) ectodomain.
    Fenouillet E; Jones I; Powell B; Schmitt D; Kieny MP; Gluckman JC
    J Virol; 1993 Jan; 67(1):150-60. PubMed ID: 8093218
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of envelope processing and gp41 membrane spanning domain in the formation of human immunodeficiency virus type 1 (HIV-1) fusion-competent envelope glycoprotein complex.
    Welman M; Lemay G; Cohen EA
    Virus Res; 2007 Mar; 124(1-2):103-12. PubMed ID: 17129629
    [TBL] [Abstract][Full Text] [Related]  

  • 37. gp160 of HIV-I synthesized by persistently infected Molt-3 cells is terminally glycosylated: evidence that cleavage of gp160 occurs subsequent to oligosaccharide processing.
    Merkle RK; Helland DE; Welles JL; Shilatifard A; Haseltine WA; Cummings RD
    Arch Biochem Biophys; 1991 Oct; 290(1):248-57. PubMed ID: 1898096
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhancing the proteolytic maturation of human immunodeficiency virus type 1 envelope glycoproteins.
    Binley JM; Sanders RW; Master A; Cayanan CS; Wiley CL; Schiffner L; Travis B; Kuhmann S; Burton DR; Hu SL; Olson WC; Moore JP
    J Virol; 2002 Mar; 76(6):2606-16. PubMed ID: 11861826
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutational analysis of the cleavage sequence of the human immunodeficiency virus type 1 envelope glycoprotein precursor gp160.
    Freed EO; Myers DJ; Risser R
    J Virol; 1989 Nov; 63(11):4670-5. PubMed ID: 2677400
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fusion of the upstream vpu sequences to the env of simian human immunodeficiency virus (SHIV(KU-1bMC33)) results in the synthesis of two envelope precursor proteins, increased numbers of virus particles associated with the cell surface and is pathogenic for pig-tailed macaques.
    Hout DR; Gomez ML; Pacyniak E; Mulcahy ER; Gomez LM; Jackson M; Flick M; Fegley B; McCormick C; Wisdom BJ; Culley N; Pinson DM; Powers M; Wong SW; Stephens EB
    Virology; 2004 May; 323(1):91-107. PubMed ID: 15165822
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.